Jove
Visualize
Contact Us

Related Experiment Video

Updated: Jul 6, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Risk stratification for positive lymph nodes in prostate cancer.

Joseph A Pettus1, Timothy A Masterson, E Jason Abel

  • 1Department of Urology, University of Utah, Salt Lake City, Utah 84132, USA.

Journal of Endourology
|April 9, 2008
PubMed
Summary

This study shows that preoperative clinical parameters can effectively stratify prostate cancer patients for lymph node involvement risk. This allows for selective omission of pelvic lymph node dissection (PLND) in low-risk cases, minimizing unnecessary procedures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

4D flow MRI for the evaluation of venous anatomy and flow in renal cell carcinoma with venous tumor thrombus: a pictorial essay.

Abdominal radiology (New York)·2026
Same author

CXCL13-CXCR5 Signaling in CD8<sup>+</sup> T Cell Recruitment and Lymphoid Immune Organization in Clear Cell Renal Cell Carcinoma.

bioRxiv : the preprint server for biology·2026
Same author

Toward protocol simplification: Deep learning-based image synthesis in three-phase CT urography.

Computers in biology and medicine·2026
Same author

Discontinuous Involvement of the Spermatic Cord by Germ Cell Tumors Should Not Be Considered Pathologic Stage M1: An International Multi-Institutional Study.

The American journal of surgical pathology·2026
Same author

Diagnostic Accuracy of Circulating Tumor DNA to Predict Retroperitoneal Histology in Patients Treated With Retroperitoneal Lymph Node Dissection for Testicular Germ Tumor.

European urology·2026
Same author

The Staging of High-risk and Non-metastatic Renal Cell Carcinoma Preoperatively Model Predicts Pathologic T3 Stage for Neoadjuvant Clinical Trial Enrollment.

Urology·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Urology
  • Oncology
  • Surgical Pathology

Background:

  • Prostate cancer management often involves assessing lymph node status.
  • Pelvic lymph node dissection (PLND) is a standard procedure but carries risks.
  • Identifying patients who can safely omit PLND is crucial for reducing morbidity.

Purpose of the Study:

  • To evaluate the efficacy of preoperative clinical parameters in predicting lymph node positivity in prostate cancer.
  • To develop a risk stratification model for nodal disease before surgery.

Main Methods:

  • Retrospective review of 760 patients undergoing radical prostatectomy (RRP) and PLND.
  • Patients were stratified into low, intermediate, and high-risk groups based on PSA, clinical stage, and Gleason score.
  • Logistic regression and ROC curve analysis were used to assess the predictive performance of the stratification.

More Related Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Related Experiment Videos

Last Updated: Jul 6, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Main Results:

  • Risk stratification was significantly associated with lymph node positivity (P<0.001).
  • The ROC curve analysis yielded an area of 0.77, indicating good predictive performance.
  • Omitting PLND in the low-risk group (49.2% of patients) would have resulted in a low false-negative rate of 1.3% for that group.

Conclusions:

  • Preoperative clinical parameters effectively stratify prostate cancer patients for the risk of lymph node metastasis.
  • Selective omission of PLND in low-risk individuals is feasible with minimal risk of missing positive nodes.
  • This approach can help reduce the number of patients undergoing unnecessary lymphadenectomy.